MD Overview

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Wall Street analysts forecast MD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MD is23.50 USD with a low forecast of 23.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Pediatrix Medical Group Inc revenue for the last quarter amounts to 476.20M USD, increased 3.89

Pediatrix Medical Group Inc. EPS for the last quarter amounts to 0.36 USD, increased 50.00

Pediatrix Medical Group Inc (MD) has 2295 emplpoyees as of May 26 2026.

Today MD has the market capitalization of 1.75B USD.